VeriMompalmitoyl tripeptide-56 est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
Pregnancy-safe products containing palmitoyl tripeptide-56
Related ingredients
Frequently asked questions
- palmitoyl tripeptide-56 est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
- palmitoyl tripeptide-56 est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity; no mechanistic data indicating transfer into breastmilk. Given low expected systemic exposure after topical use, systemic levels are likely minimal but not zero, so exposure is low/measurable. Sources: PubMed (no relevant studies), ECHA (no harmonised classification), PubChem/CosIng (ingredient identity/uses).
- palmitoyl tripeptide-56 est-il sûr pour la peau de bébé ?
- No infant‑specific toxicity or developmental effects reported. Per guidance, infant skin has higher per‑kg exposure and a less mature barrier; for an ingredient with low but measurable adult absorption (e=1), increase exposure score by +1 for babies (e=2). No data support increased hazard or specific mechanisms in infants. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient info).
- Comment VeriMom évalue-t-il palmitoyl tripeptide-56 ?
- VeriMom évalue palmitoyl tripeptide-56 à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à palmitoyl tripeptide-56 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à palmitoyl tripeptide-56 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.